Effects of cannabinoids on dopamine release in the corpus striatum and the nucleus accumbens in vitro

Journal of Neurochemistry

Volumn 73, Issue 3, 1999, Pages 1084-1089

  Szabo, Bela ^a   Müller, Tobias ^a   Koch, Helga ^a  

^a UNIVERSITY OF FREIBURG   (Germany)

Author keywords

Cannabinoid receptor; Corpus striatum; Dopamine release; Nucleus accumbens; Presynaptic receptor; Voltammetry

Indexed keywords

2,3 DIHYDRO 5 METHYL 3 (MORPHOLINOMETHYL) 6 (1 NAPHTHOYL)PYRROLO[1,2,3 DE][1,4]BENZOXAZINE; 3,4 DICHLORO N METHYL N [2 (1 PYRROLIDINYL)CYCLOHEXYL]BENZENEACETAMIDE; 4 (1,1 DIMETHYLHEPTYL) 1',2',3',4',5',6' HEXAHYDRO 2,3' DIHYDROXY 6' (3 HYDROXYPROPYL)BIPHENYL; CANNABINOID; CANNABINOID RECEPTOR; PRESYNAPTIC RECEPTOR; QUINPIROLE; RIMONABANT;

ANIMAL TISSUE; ARTICLE; BRAIN SLICE; CORPUS STRIATUM; DOPAMINE RELEASE; ELECTROSTIMULATION; EXTRAPYRAMIDAL SYMPTOM; LIMBIC CORTEX; MALE; NIGRONEOSTRIATAL SYSTEM; NONHUMAN; NUCLEUS ACCUMBENS; PERIKARYON; PRESYNAPTIC NERVE; PRIORITY JOURNAL; RAT; REWARD; SUBSTANTIA NIGRA; VENTRAL TEGMENTUM;

3,4-DICHLORO-N-METHYL-N-(2-(1-PYRROLIDINYL)-CYCLOHEXYL)-BENZENEACETAMIDE, (TRANS)-ISOMER; ANIMALS; CANNABINOIDS; CORPUS STRIATUM; CYCLOHEXANOLS; DOPAMINE; DOPAMINE AGONISTS; ELECTRIC STIMULATION; ELECTROPHYSIOLOGY; MALE; MEMBRANE POTENTIALS; MORPHOLINES; NAPHTHALENES; NUCLEUS ACCUMBENS; PATCH-CLAMP TECHNIQUES; QUINPIROLE; RATS; RATS, WISTAR; RECEPTOR, CANNABINOID, CB2; RECEPTORS, CANNABINOID; RECEPTORS, DRUG; RECEPTORS, OPIOID, KAPPA;

EID: 0344199383     PISSN: 00223042     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1471-4159.1999.0731084.x     Document Type: Article

References (32)

1. Bull D. R. and Sheehan M. J. (1991) Presynaptic regulation of electrically evoked dopamine overflow in nucleus accumbens: a pharmacological study using fast cyclic voltammetry in vitro. Naunyn Schmiedebergs Arch. Pharmacol. 343, 260-265.
2. Cadogan A.-K., Alexander S. P. H., Boyd A. E., and Kendall D. A. (1997) Influence of cannabinoids on electrically evoked dopamine release and cyclic AMP generation in the rat striatum. J. Neurochem. 69, 1131-1137.
3. Compton D. R., Harris L. S., Lichtman A. H., and Martin B. R. (1996) Marihuana, in Handbook of Experimental Pharmacology, Vol. 118: Pharmacological Aspects of Drug Dependence (Schuster C. R. and Kuhar M. J., eds), pp. 83-158. Springer, Heidelberg.
4. Fallon J. H. and Loughlin S. E. (1995) Substantia nigra, in The Rat Nervous System (Paxinos G., ed), pp. 215-237. Academic Press, San Diego.
5. Felder C. C., Joyce K. E., Briley E. M., Mansouri J., Mackie K., Blond O., Lai Y., Ma A. L., and Mitchell R. L. (1995) Comparison of the pharmacology and signal transduction of the human cannabinoid CB1 and CB2 receptors. Mol. Pharmacol. 48, 443-450.
6. Gessa G., Melis M., Muntoni A., and Diana M. (1998) Cannabinoids activate mesolimbic dopamine neurons by an action on cannabinoid CB1 receptors. Eur. J. Pharmacol. 341, 39-44.
7. Healy D. J. and Meador-Woodruff J. H. (1996) Differential regulation, by MK-801, of dopamine receptor gene expression in rat nigrostriatal and mesocorticolimbic systems. Brain Res. 708, 38-44.
8. Heijna M. H., Padt M., Hogenboom F., Portoghese P. S., Mulder A. H., and Schoffelmeer N. M. (1990) Opioid receptor-mediated inhibition of dopamine and acetylcholine release from slices of rat nucleus accumbens, olfactory tubercle and frontal cortex. Eur. J. Pharmacol. 18, 267-278.
9. Herkenham M., Lynn A. B., De Costa B. R., and Richfield E. K. (1991) Neuronal localization of cannabinoid receptors in the basal ganglia of the rat. Brain Res. 547, 267-274.
10. Howlett A. C. (1995) Pharmacology of cannabinoid receptors. Annu. Rev. Pharmacol. Toxicol. 35, 607-634.
11. Jansen E. M., Haycock D. A., Ward S. J., and Seybold V. S. (1992) Distribution of cannabinoid receptors in rat brain determined with aminoalkylindoles. Brain Res. 575, 93-102.
12. Jin S. and Fredholm B. B. (1997) Electrically-evoked dopamine and acetylcholine release from rat striatal slices perfused without magnesium: regulation by glutamate acting on NMDA receptors. Br. J. Pharmacol. 121, 1269-1276.
13. Kuster J. E., Stevenson J. I., Ward S. J., D'Ambra T. E., and Haycock D. A. (1993) Aminoalkylindole binding in rat cerebellum: selective displacement by natural and synthetic cannabinoids. J. Pharmacol. Exp. Ther. 264, 1352-1363.
14. Limberger N., Trout S. J., Kruk Z. L., and Starke K. (1991) "Real time" measurement of endogenous dopamine release during short trains of pulses in slices of rat neostriatum and nucleus accumbens: role of autoinhibition. Naunyn Schmiedebergs Arch. Pharmacol. 344, 623-629.
15. Mailleux P. and Vanderhaeghen J.-J. (1992) Distribution of neuronal cannabinoid receptor in the adult rat brain: a comparative receptor binding radioautography and in situ hybridization histochemistry. Neuroscience 48, 655-668.
16. Mansour A., Fox C. A., Akil H., and Watson S. J. (1995) Opioid-receptor mRNA expression in the rat CNS: anatomical and functional implications. Trends Neurosci. 18, 22-29.
17. Martellotta M. C., Cossu G., Fattore L., Gessa G. L., and Fratta W. (1998) Self-administration of the cannabinoid receptor agonist WIN 55,212-2 in drug-naive mice. Neuroscience 85, 327-330.
18. Matsuda L. A., Bonner T. I., and Lolait S. J. (1993) Localization of cannabinoid receptor mRNA in rat brain. J. Comp. Neurol. 327, 535-550.
19. Mulder A. H., Burger D. M., Wardeh G., Hogenboom F., and Frankhuyzen A. L. (1991) Pharmacological profile of various kappa-agonists at kappa-, mu-and delta-opioid receptors mediating presynaptic inhibition of neurotransmitter release in the rat brain. Br. J. Pharmacol. 102, 518-522.
20. Pertwee R. G. (1997) Pharmacology of cannabinoid CB1 and CB2 receptors. Pharmacol. Ther. 74, 129-180.
21. Pertwee R. G. and Fernando S. R. (1996) Evidence for the presence of cannabinoid CB1 receptors in mouse urinary bladder. Br. J. Pharmacol. 118, 2053-2058.
22. Pertwee R. G., Stevenson L. A., Elrick D. B., Mechoulam R., and Corbett A. D. (1992) Inhibitory effects of certain enantiomeric cannabinoids in the mouse vas deferens and the myenteric plexus preparation of guinea-pig small intestine. Br. J. Pharmacol. 105, 980-984.
23. Romero J., Garcia-Palomero E., Castro J. G., Garcia-Gil L., Ramos J. A., and Fernandez-Ruiz J. J. (1997) Effects of chronic exposure to delta-9-tetrahydrocannabinol on cannabinoid receptor binding and mRNA levels in several rat brain regions. Mol. Brain. Res. 46, 100-108.
24. Schlicker E., Timm J., and Göthert M. (1996) Cannabinoid receptor-mediated inhibition of dopamine release in the retina. Naunyn Schmiedebergs Arch. Pharmacol. 354, 791-795.
25. Showalter V. M., Compton D. R., Martin B. R., and Abood M. E. (1996) Evaluation of binding in a transfected cell line expressing a peripheral cannabinoid receptor (CB2): identification of cannabinoid receptor subtype selective ligands. J. Pharmacol. Exp. Ther. 278, 989-999.
26. Stamford J. A. (1995) Voltammetry in brain slices, in Brain Slices in Basic and Clinical Research (Schurr A. and Rigor B., eds), pp. 65-88. CRC Press, Boca Raton, Florida.
27. Starke K., Göthert M., and Kilbinger H. (1989) Modulation of neurotransmitter release by presynaptic autoreceptors. Physiol. Rev. 69, 864-989.
28. Suzuki M., Hurd Y. L., Sokoloff P., Schwartz J.-C., and Sedvall G. (1998) D3 dopamine receptor mRNA is widely expressed in the human brain. Brain Res. 779, 58-74.
29. Szabo B. and Pfreundtner C. (1998) Effects of cannabinoids on glutamatergic neurotransmission in the substantia nigra. Naunyn Schmiedebergs Arch. Pharmacol. 357, R31.
30. Szabo B., Dörner L., Pfreundtner C., Nörenberg W., and Starke K. (1998) Inhibition of GABAergic inhibitory postsynaptic currents by cannabinoids in rat corpus striatum. Neuroscience 85, 395-403.
31. Tanda G., Pontieri F. E., and Di Chiara G. (1997) Cannabinoid and heroin activation of mesolimbic dopamine transmission by a common mu opioid receptor mechanism. Science 276, 2048-2050.
32. Tsou K., Brown S., Sanudo-Pena M. C., Mackie K., and Walker J. M. (1998) Immunohistochemical distribution of cannabinoid CB1 receptors in the rat central nervous system. Neuroscience 83, 393-411.